Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sonia Alavi, Mohammad A. Mahjoob, Azadeh Haeri, Farshad H. Shirazi, Zahra Abbasian & Simin Dadashzadeh. (2021) Multivesicular liposomal depot system for sustained delivery of risperidone: development, characterization, and toxicity assessment. Drug Development and Industrial Pharmacy 47:8, pages 1290-1301.
Read now
Read now
Madeleine S. A. Tan, Harendra S Parekh, Preeti Pandey, Dan J. Siskind & James R. Falconer. (2020) Nose-to-brain delivery of antipsychotics using nanotechnology: a review. Expert Opinion on Drug Delivery 17:6, pages 839-853.
Read now
Read now
Bushra Nabi, Saleha Rehman, Mohammad Fazil, Saba Khan, Sanjula Baboota & Javed Ali. (2020) Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Development and Industrial Pharmacy 46:3, pages 471-483.
Read now
Read now
Articles from other publishers (19)
BHARGAVI POSINASETTY, SRIVIDYA KOMMINENI, RAJASEKHAR KOMARLA KUMARACHARI & KISHORE BANDARAPALLE. (2023) DESIGN AND OPTIMIZATION OF NANO ENCAPSULATED BERBERIS ASIATICA BIO COMPOUNDS. International Journal of Applied Pharmaceutics, pages 241-255.
Crossref
Crossref
Siva Prasad Panda & Vikrant Singh. (2023) The Dysregulated MAD in Mad: A Neuro-theranostic Approach Through the Induction of Autophagic Biomarkers LC3B-II and ATG. Molecular Neurobiology 60:9, pages 5214-5236.
Crossref
Crossref
Enas Elmowafy & Mahmoud E. Soliman. (2023) Polysaccharide-based platforms for nasal delivery: design, features, and perspectives. Journal of Pharmaceutical Investigation.
Crossref
Crossref
Jon Ander Simón, Emilia Utomo, Félix Pareja, María Collantes, Gemma Quincoces, Aarón Otero, Margarita Ecay, Juan Domínguez-Robles, Eneko Larrañeta & Iván Peñuelas. (2023) Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development. Pharmaceutics 15:3, pages 843.
Crossref
Crossref
Charitha Thambiliyagodage, Madara Jayanetti, Amavin Mendis, Geethma Ekanayake, Heshan Liyanaarachchi & Saravanamuthu Vigneswaran. (2023) Recent Advances in Chitosan-Based Applications—A Review. Materials 16:5, pages 2073.
Crossref
Crossref
Anroop B. Nair, Sunita Chaudhary, Shery Jacob, Dhwani Patel, Pottathil Shinu, Hiral Shah, Ankit Chaudhary, Bandar Aldhubiab, Rashed M. Almuqbil, Ahmed S. Alnaim, Fatemah Alqattan & Jigar Shah. (2023) Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting. Gels 9:2, pages 130.
Crossref
Crossref
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery
339
360
.
Tejas Girish Agnihotri, Govinda Shivaji Jadhav, Bichismita Sahu & Aakanchha Jain. (2022) Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders. Drug Delivery and Translational Research 12:12, pages 3104-3120.
Crossref
Crossref
Emilia Utomo, Juan Domínguez-Robles, Natalia Moreno-Castellanos, Sarah A. Stewart, Camila J. Picco, Qonita Kurnia Anjani, Jon Ander Simón, Iván Peñuelas, Ryan F. Donnelly & Eneko Larrañeta. (2022) Development of intranasal implantable devices for schizophrenia treatment. International Journal of Pharmaceutics 624, pages 122061.
Crossref
Crossref
Shuai Zha, Ka‐Leung Wong & Angelo H. All. (2022) Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Advanced Healthcare Materials 11:11, pages 2102610.
Crossref
Crossref
Anroop B. Nair, Sunita Chaudhary, Hiral Shah, Shery Jacob, Vivek Mewada, Pottathil Shinu, Bandar Aldhubiab, Nagaraja Sreeharsha, Katharigatta N. Venugopala, Mahesh Attimarad & Jigar Shah. (2022) Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies. Gels 8:6, pages 342.
Crossref
Crossref
Rajalakshmi Rajendran, Krishnakumar Neelakandha MenonSreeja Chandrasekharan Nair. (2021) Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia. Advanced Pharmaceutical Bulletin 12:3, pages 490-508.
Crossref
Crossref
Sara Garcinuño, Inmaculada Aranaz, Concepción Civera, Concepción Arias & Niuris Acosta. (2022) Evaluating Non-Conventional Chitosan Sources for Controlled Release of Risperidone. Polymers 14:7, pages 1355.
Crossref
Crossref
Maria Camilla Bergonzi, Anna Rita Bilia & Elisa Landucci. (2022) Applications of innovative technologies to the delivery of antipsychotics. Drug Discovery Today 27:2, pages 401-421.
Crossref
Crossref
N. N. Porfiryeva, I. I. Semina, R. I. Moustafine & V. V. Khutoryanskiy. (2021) Intranasal Administration as a Route to Deliver Drugs to the Brain (Review). Drug development & registration 10:4, pages 117-127.
Crossref
Crossref
Mansi Bhanderi, Jigar Shah, Bapi Gorain, Anroop B. Nair, Shery Jacob, Syed Mohammed Basheeruddin Asdaq, Santosh Fattepur, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Sreeharsha Nagaraja & Md. Khalid Anwer. (2021) Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials 14:21, pages 6291.
Crossref
Crossref
Maira Anwar, Faqir Muhammad & Bushra Akhtar. (2021) Biodegradable nanoparticles as drug delivery devices. Journal of Drug Delivery Science and Technology 64, pages 102638.
Crossref
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Liroy Lugasi, Igor Grinberg, Rivka Sabag, Ravit Madar, Haim Einat & Shlomo Margel. (2020) Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone. Molecules 25:17, pages 4013.
Crossref
Crossref